Bain & Company July 11, 2023
By David Harding, Dale Stafford, and Suzanne Kumar

The strategic M&A market is in limbo as both buyers and sellers navigate this weird economy.

At a Glance

  • Overall global M&A value is down 44% in the first five months of 2023.
  • Macroeconomic and interest rate uncertainty continues to complicate dealmaking and foster caution among sellers and buyers alike.
  • Valuations for strategic technology deals declined dramatically, but valuations have held steady or ticked up in most other sectors.
  • Dealmaking is likely to resume faster than many have anticipated and favor the best-prepared buyers and sellers.

We’re now 12 months into a lethargic mergers-and-acquisitions market, with deal values and volume well off postpandemic highs. Consider the mixed signals dealmakers...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Mergers & Acquisitions / JV, Survey / Study, Trends
Prisma Health CEO on the system's 1st out-of-state acquisition, growth plans
UnitedHealth wants earlier date for Amedisys merger trial
3 payer M&A deals start 2025
'Optimism' for healthcare M&A in 2025: 5 notes
“Hospital Mergers Kill”: An Economists’ Exercise in Reality Distortion

Share This Article